
Terence M. Williams: Super proud of our progress in Radiation Oncology at COH
Terence M. Williams, Professor & Chair at City of Hope, Radiation Oncology made the following post on LinkedIn:
“Super proud of our progress in Radiation Oncology at COH. Much has changed in the last 2-3 years and we have grown so fast.
Clinically, tremendous growth in SoCal with 28-33% increases in gross revenues and wRVU productivity, with paralleled significant increases in treatment starts, while maintaining extremely high levels of operational efficiency.
On the academic side, we have seen year or year growth in research funding (>90% growth in the last 3 years), RadOnc PI-led clinical trials (209% growth), and clinical trial accruals by RadOnc PIs (222% growth), with many new faculty PI funded clinical trials. Growth in publications, hundreds per year with >25% increase in median impact factor.
Investments in unification of our RT planning software and hardware, roll-out of auto-segmentation, common EMR, surface-guided radiotherapy programs to enhance collaboration, efficiencies, and connectivity. Not to mention our conceptual integration and standardization through our new RadOnc Disease Teams, and quality programs (ASTRO APEx, toxicity reporting, peer review).
Proud that our Press-Ganey patient satisfaction scores are higher than the average for City of Hope (94%tile vs 89%tile). Changes to our residency program, and growth of our RTT programs highlights our commitment to education. We have started to leverage our vast RadOnc Network in SoCal (4 counties including LA, Orange, Riverside, and SB). The addition of our centers in Phoenix, Atlanta, and Chicago will further boost our missions.
I’m thankful to Michael Caligiuri, Jeff Walker, Robert Stone, Steve Rosen, Vijay Trisal, Vince Jensen, Ashley Lee, Jeff Trent, many others for providing the opportunity to transform RadOnc at City of Hope. Very appreciative of our internal leadership team (Louis M, Phyllis B, An Liu, Les Botnick, Milt H, Kim H), not to mention our tremendous team of admin directors, physicians, physicists, nurses, dosimetrists, therapists, schedulers, and more. I look forward to further building upon our successes with our new President of NMC Dr. Marcel van den Brink and new Chief Scientific Officer/CCC Director Dr. John Carpten.
Incredibly honored by the many faculty who have joined me on this ride, including Percy Lee, Jose Bazan, Rose Li, Heather McGee, Stephanie Yoon, Yufei Liu, Sean Maroongroge, Amanda Schwer, Bory Eastman, Trevor Lim, Peter Wu, Nina Cote, April V, Borna M, Bo Liu, Todd DeWees, so many more recruits. To those who stayed and accepted change- thank you.
Lots of excitement to come, with launching of real-time BgRT (SCINTIX) programs, our adaptive programs (CT/MRI), theranostics, and continuing innovation in our other research programs including radiogenomics, radioimmunomodulation, and TMLI/TMI. We will leverage our National RadOnc Network for clinical trials, our clinical registry/database for research/ & quality, and PRO/QOL studies as first steps.
The future is bright and I look forward to see what we can further accomplish as a team!”
Source: Terence M. Williams/LinkedIn
-
17:28 29/11JeeSuk Chang: A multi-center trial - great efforts from the KROG team
-
17:00 29/11Maite Bourlon: Access to novel drugs for metastatic renal cell carcinoma is an unmet need in the Mexican population
-
23:17 28/11Manni Mohyuddin: Current trials must have observation/surveillance as control arm
-
23:04 28/11Juan P. Alderuccio: Our approach to secondary CNS involvement by aggressive lymphomas
-
17:17 27/11Vivek Subbiah: Treatment patterns and overall survival (OS) in patients with advanced NSCLC in three countries between 2011 and 2020
-
17:43 28/11Michele Carbone: The world is full of good, honest, nice people
-
17:24 28/11Jessica Clerc: Celebrating 90 Years of Excellence and Dedication in Cancer Care!
-
17:44 25/11Carlos Pedraz: Congratulations, Dr. Rafael Rosell for the very well deserved 2023 ISLB Lifetime Achievement Award
-
17:10 25/11100 Influential Celebrities in Oncology: The 2023 Edition – Part 4
-
13:34 24/11"Bald for a Cause" initiative - UWC Dilijan College
-
17:34 28/11The International Association of Cancer Registries annual conference - IARC
-
18:05 26/11Submit your abstract by 13 February for ESMO-Breast-24 - ESMO
-
17:58 26/11Lisa A. Lacasse: My sincere gratitude to the ACS CAN team, our incredible volunteers, and supporters for another outstanding year
-
16:47 16/11How social determinants can influence a patient’s ability to stay in treatment - ASCO
-
13:22 16/11SIOP Europe Student Summer School for Paediatric Oncology
-
17:25 29/11NIH Director’s Early Independence Award supports junior scientists to launch independent careers - National Cancer Institute
-
17:07 29/11Santhosh Kumar Devadas: I’m starting a new position as a Professor of Medical Oncology and Chief of Bone Marrow Transplant at Ramaiah Memorial Hospital and Ramaiah Medical College
-
16:48 27/11CRCHD seeks motivated scientists to serve as Program Directors - NCI Disparities
-
16:25 27/11Luisa Basset completed a fruitful nine-year tenure on the CCI board of trustees - Childhood Cancer International
-
18:14 26/11Tristan Knight: Attention hematology / oncology and pediatric hematology / oncology fellows